By improving insulin sensitivity, stabilizing glucose levels, optimizing lipid metabolism, and improving cerebrovascular function, MedDiet has been proven to reduce the risk of stroke, MCI, and AD in T2DM patients. This evidence concerns the gene INS and type 2 diabetes mellitus.